https://scholars.lib.ntu.edu.tw/handle/123456789/575432
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.author | Huang, Yen-Hsiang | en_US |
dc.contributor.author | Hung, Jen-Yu | en_US |
dc.contributor.author | Ko, How-Wen | en_US |
dc.contributor.author | Su, Po-Lan | en_US |
dc.contributor.author | Lai, Chun-Liang | en_US |
dc.contributor.author | Chang, Huang-Chih | en_US |
dc.contributor.author | Hsia, Te-Chun | en_US |
dc.contributor.author | Lin, Sheng-Hao | en_US |
dc.contributor.author | Wu, Kuan-Li | en_US |
dc.contributor.author | Yang, Cheng-Ta | en_US |
dc.contributor.author | Su, Wu-Chou | en_US |
dc.contributor.author | Chu, Yi-Chun | en_US |
dc.contributor.author | Wang, Chin-Chou | en_US |
dc.contributor.author | WEI-YU LIAO | en_US |
dc.contributor.author | YEN-TING LIN | en_US |
dc.contributor.author | Lin, Ching-Hsiung | en_US |
dc.contributor.author | Lin, Meng-Chih | en_US |
dc.contributor.author | Hsu, Kuo-Hsuan | en_US |
dc.contributor.author | Tseng, Jeng-Sen | en_US |
dc.contributor.author | Yang, Tsung-Ying | en_US |
dc.contributor.author | Chen, Kun-Chieh | en_US |
dc.contributor.author | Lee, Mei-Hsuan | en_US |
dc.contributor.author | SUNG-LIANG YU | en_US |
dc.contributor.author | CHAO-CHI HO | en_US |
dc.contributor.author | Chang, Gee-Chen | en_US |
dc.date.accessioned | 2021-07-30T01:32:10Z | - |
dc.date.available | 2021-07-30T01:32:10Z | - |
dc.date.issued | 2021 | - |
dc.identifier.issn | 1758-8340 | - |
dc.identifier.uri | https://scholars.lib.ntu.edu.tw/handle/123456789/575432 | - |
dc.description.abstract | The relative importance of predictive factors for advanced non-small cell lung cancer (NSCLC) patients on epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor (TKI) treatment remains unclear. | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | Therapeutic advances in medical oncology | en_US |
dc.subject | epidermal growth factor receptor; local treatment; more than five years; non-small cell lung cancer; scoring model; tyrosine kinase inhibitor | en_US |
dc.subject.classification | [SDGs]SDG3 | - |
dc.subject.other | epidermal growth factor receptor; erlotinib; gefitinib; protein tyrosine kinase inhibitor; accuracy; adrenal metastasis; adult; advanced cancer; aged; allele; amino acid sequence; area under the curve; Article; biopsy; bone metastasis; brain metastasis; cancer patient; cancer radiotherapy; cancer recurrence; cancer research; cancer staging; cancer surgery; chemoradiotherapy; chronic patient; cohort analysis; computer assisted tomography; confidence interval; controlled study; diagnostic test accuracy study; disease exacerbation; DNA sequence; ECOG Performance Status; exon; female; follow up; gene mutation; genetic screening; heterozygote; human; human cell; human tissue; liquid biopsy; liver metastasis; local therapy; lung cancer; lung lesion; major clinical study; male; mass spectrometry; medical history; multicenter study; non small cell lung cancer; plasma cell; postoperative complication; prediction; predictive value; prevalence; primary tumor; receiver operating characteristic; retrospective study; risk factor; scoring system; sensitivity and specificity; small cell lung cancer; smoking; stomach cancer; system analysis | - |
dc.title | The relative importance of predictive factors for single first-generation EGFR-TKI use for more than 5 years in patients with advanced non-small cell lung cancer: Taiwan multicenter TIPS-5 study | en_US |
dc.type | journal article | en |
dc.identifier.doi | 10.1177/17588359211018022 | - |
dc.identifier.pmid | 34093743 | - |
dc.identifier.scopus | 2-s2.0-85106656727 | - |
dc.identifier.url | https://scholars.lib.ntu.edu.tw/handle/123456789/571107 | - |
dc.relation.journalvolume | 13 | en_US |
item.languageiso639-1 | en | - |
item.cerifentitytype | Publications | - |
item.fulltext | no fulltext | - |
item.openairecristype | http://purl.org/coar/resource_type/c_6501 | - |
item.openairetype | journal article | - |
item.grantfulltext | none | - |
crisitem.author.dept | Internal Medicine | - |
crisitem.author.dept | Internal Medicine-NTUH | - |
crisitem.author.dept | Medicine-NTUCC | - |
crisitem.author.dept | Internal Medicine | - |
crisitem.author.dept | Clinical Laboratory Sciences and Medical Biotechnology | - |
crisitem.author.dept | Pathology | - |
crisitem.author.dept | Medical Device and Imaging | - |
crisitem.author.dept | Internal Medicine | - |
crisitem.author.dept | Internal Medicine-NTUH | - |
crisitem.author.orcid | 0000-0001-6383-3470 | - |
crisitem.author.orcid | 0000-0002-3350-9140 | - |
crisitem.author.orcid | 0000-0003-4535-9036 | - |
crisitem.author.orcid | 0000-0002-8156-2413 | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | National Taiwan University Cancer Center (NTUCC) | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
顯示於: | 醫學檢驗暨生物技術學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。